临床药师干预对脑梗死患者用药依从性的影响

邵腾飞; 葛卫红; 邵腾飞; 葛卫红

doi:10.3969/j.issn.1006-0111.2017.02.021

[1]	Grunberg SM, Deuson RR, Mavros P, et al. Incidence of chemotherapy-induced nausea and emesis after modern antiemetics[J]. Cancer, 2004, 100(10):2261-2268.
[2]	余华琴,陈华英,任若梅,等. 阿瑞匹坦三联止吐方案用于接受高致吐方案化疗患者的疗效观察[J]. 现代中西医结合杂志,2016,25(3):274-276.
[3]	田奕,王平,马丽君.应用R-INVR国际量表评估阿瑞匹坦、欧赛、地塞米松对于乳腺癌患者化疗所致中重度呕吐治疗效果观察[J]. 中国现代医学杂志,2016,26(18):136-139.
[4]	Hesketh PJ. Comparative review of 5-HT3 receptor antagonists in the treatment of acute chemotherapy-induced nausea and vomiting[J]. Cancer Invest, 2000, 18(2):163-173.
[5]	于莉,张晓晔.阿瑞匹坦在实体肿瘤化疗止吐治疗的研究进展[J]. 中国肿瘤临床与康复,2016,23(9):1148-1152.
[6]	Aapro M, Carides A, Rapoport BL, et al. Aprepitant and fosaprepitant:a 10-year review of efficacy and safety[J]. Oncnlogist, 2015, 20(4):450-458.
[7]	郑琪,廖子君,李旭,等. 阿瑞匹坦治疗化疗诱导的爆发性恶心呕吐的临床观察[J]. 山西医科大学学报,2016,47(6):539-543.
[8]	Chu CC, Hsing CH, Shieh JP, et al. The cellular mechanisms of the antiemetic action of dexamethasone and related glucocorticoids against vomiting[J]. Eur J Pharmacol, 2014, 722:48-54.
[9]	丁荣楣,王平,田奕,等. 阿瑞匹坦辅助预防乳腺癌FAC方案化疗致恶心呕吐的临床观察[J]. 疑难病杂志,2015,14(1):45-48.